| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Assessment of Studies Evaluating Incremental Costs, Effectiveness, or Cost-Effectiveness of Systemic Therapies in Breast Cancer Based on Claims Data: A Systematic Review
|
Luyendijk, Marianne
|
|
|
23 |
11 |
p. 1497-1508
|
artikel
|
| 2 |
Being Precise About Precision Medicine: What Should Value Frameworks Incorporate to Address Precision Medicine? A Report of the Personalized Precision Medicine Special Interest Group
|
|
|
|
23 |
11 |
p. 1522
|
artikel
|
| 3 |
Copyright/Subscription
|
|
|
|
23 |
11 |
p. iv
|
artikel
|
| 4 |
Coronavirus Disease 2019: Considerations for Health Technology Assessment From the National Centre for Pharmacoeconomics Review Group
|
Leahy, Joy
|
|
|
23 |
11 |
p. 1423-1426
|
artikel
|
| 5 |
Cost-Effectiveness of Antiviral Treatments for Pandemics and Outbreaks of Respiratory Illnesses, Including COVID-19: A Systematic Review of Published Economic Evaluations
|
Dawoud, Dalia M.
|
|
|
23 |
11 |
p. 1409-1422
|
artikel
|
| 6 |
Cost-Effectiveness of Immediate Magnetic Resonance Imaging In the Management of Patients With Suspected Scaphoid Fracture: Results From a Randomized Clinical Trial
|
Rua, Tiago
|
|
|
23 |
11 |
p. 1444-1452
|
artikel
|
| 7 |
Costing the COVID-19 Pandemic: An Exploratory Economic Evaluation of Hypothetical Suppression Policy in the United Kingdom
|
Zala, Darshan
|
|
|
23 |
11 |
p. 1432-1437
|
artikel
|
| 8 |
Editorial Board
|
|
|
|
23 |
11 |
p. v
|
artikel
|
| 9 |
Head-to-Head Comparison of the Psychometric Properties of 3 Carer-Related Preference-Based Instruments
|
McCaffrey, Nikki
|
|
|
23 |
11 |
p. 1477-1488
|
artikel
|
| 10 |
Informing Balanced Investment in Services and Health Systems: A Case Study of Priority Setting for Tuberculosis Interventions in South Africa
|
Bozzani, Fiammetta M.
|
|
|
23 |
11 |
p. 1462-1469
|
artikel
|
| 11 |
Measuring “Fearonomic Effects” in Valuing Therapies: An Application to COVID-19 in China
|
Ma, Siyu
|
|
|
23 |
11 |
p. 1405-1408
|
artikel
|
| 12 |
Modifying the Criteria for Granting Orphan Drug Market Exclusivity
|
Socal, Mariana P.
|
|
|
23 |
11 |
p. 1470-1476
|
artikel
|
| 13 |
Optimization Models for HIV/AIDS Resource Allocation: A Systematic Review
|
Avanceña, Anton L.V.
|
|
|
23 |
11 |
p. 1509-1521
|
artikel
|
| 14 |
Practical Guidance for Including Future Costs in Economic Evaluations in The Netherlands: Introducing and Applying PAID 3.0
|
Kellerborg, Klas
|
|
|
23 |
11 |
p. 1453-1461
|
artikel
|
| 15 |
Table of Contents
|
|
|
|
23 |
11 |
p. i-iii
|
artikel
|
| 16 |
Testing the “Nonstopping” Time Trade-Off: Is It Better Than the Composite Time Trade-Off?
|
Luo, Nan
|
|
|
23 |
11 |
p. 1489-1496
|
artikel
|
| 17 |
The Economic and Public Health Imperatives Around Making Potential Coronavirus Disease–2019 Treatments Available and Affordable
|
Forsythe, Steven
|
|
|
23 |
11 |
p. 1427-1431
|
artikel
|
| 18 |
The Role of Health Economics and Outcomes Research in Addressing Coronavirus Disease 2019 (COVID-19)
|
Mullins, C. Daniel
|
|
|
23 |
11 |
p. 1403-1404
|
artikel
|
| 19 |
Willingness to Accept Trade-Offs Among COVID-19 Cases, Social-Distancing Restrictions, and Economic Impact: A Nationwide US Study
|
Reed, Shelby
|
|
|
23 |
11 |
p. 1438-1443
|
artikel
|
Tijdschrift beschrijving